IN THE MANAGEMENT of carcinoma of the lung, the most effective means for cure is probably surgical resection. However, the proportion of patients eligible for curative resection is relatively small. Garland2 reports that only about 20% of those with symptoms and about 40% of those without symptoms are eligible for curative surgery. Certainly no patient should be denied the opportunity for definitive surgery with extended resection of the involved lobe and the involved regional lymph nodes, when indicated.
Best results are to be anticipated if an experienced clinical team should carefully evaluate each patient with carcinoma of the lung. Emphasis should be placed on the resectability of the lesion, the ability of the patient to withstand the procedure, and the predictability of postoperative complications. In spite of great care in the selection of patients for operation, the total five-year survival rates with surgery alone are frustratingly poor, being variously
BRADY LW, CANDER L, EVANS GC, FAUST DS. Carcinoma of the LungResults of Supervoltage Radiation Therapy. Arch Surg. 1965;90(1):90-94. doi:10.1001/archsurg.1965.01320070092020